Communiqués KYORIN Pharmaceutical Co., Ltd.

Actions

4569

JP3247090008

Produits pharmaceutiques

Marché Fermé - Japan Exchange 08:30:00 30/09/2026			Varia. 5j.	Varia. 1 janv.
1 105,00 ^JPY	-0,27%		-2,04%	-28,11%

03/08	KYORIN Pharmaceutical Co., Ltd. lance la promotion de la crème palpébrale Alesion 0,5 % pour le traitement de la conjonctivite allergique	CI
13/07	KYORIN Pharmaceutical et Santen Pharmaceutical concluent un accord de co-commercialisation pour la crème Alesion 0,5 %, traitement de la conjonctivite allergique	CI

Communiqués

13/05	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (May 12, 2026)	PU
13/05	KYORIN Pharmaceutical : Supplementary Information (May 12, 2026)	PU
13/05	KYORIN Pharmaceutical : Presentation document (May 13, 2026)	PU
13/05	KYORIN Pharmaceutical : New Medium-Term Business Plan	PU
04/02	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (February 4, 2026)	PU
04/02	KYORIN Pharmaceutical : Supplementary Information (February 4, 2026)	PU
10/11	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (November 7, 2025)	PU
10/11	KYORIN Pharmaceutical : Supplementary Information (November 7, 2025)	PU
28/10/25	KYORIN Pharmaceutical : Integrated Report 2025 Batch download (2 Page spread) [	PU
31/07/25	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (July 31, 2025)	PU
31/07/25	KYORIN Pharmaceutical : Supplementary Information (July 31, 2025)	PU
15/05/25	KYORIN Pharmaceutical : Presentation document (May 13, 2025)	PU
12/05/25	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (May 12, 2025)	PU
12/05/25	KYORIN Pharmaceutical : Supplementary Information (May 12, 2025)	PU
19/02/25	KYORIN Pharmaceutical and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan	AQ
05/02/25	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (February 5, 2025)	PU
05/02/25	KYORIN Pharmaceutical : Supplementary Information (February 5, 2025)	PU
07/11/24	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (November 7, 2024)	PU
07/11/24	KYORIN Pharmaceutical : Supplementary Information (November 7, 2024)	PU
07/11/24	KYORIN Pharmaceutical : Presentation document (November 8, 2024)	PU
30/09/24	KYORIN Pharmaceutical : Integrated Report 2024 Batch download (2 Page spread) [ 4.	PU
01/08/24	KYORIN Pharmaceutical : Summary of Consolidated Financial Results (July 31, 2024)	PU
01/08/24	KYORIN Pharmaceutical : Supplementary Information (July 31, 2024)	PU
13/05/24	KYORIN Pharmaceutical : Supplementary Information (May 11, 2024)	PU
29/09/23	KYORIN Pharmaceutical : Integrated Report 2023 Batch download (Single Page) [ 10.6MB	PU